Most Recent Articles by Jody A. Charnow, Editor
Treatment with this compound resulted in higher circulating levels of 25(OH)D compared with ergocalciferol in Hispanic CKD patients.
Preoperative weight loss greater than 10% and operative time more than 6 hours also increased the risk.
Donor and recipient outcomes are similar to those associated with laparoscopic removal of left donor kidneys.
In a study, the treatment was associated with a 53% decreased risk of death from kidney cancer compared with expectant management.
Ten years after the laser procedure, no reoperation was needed for 95% of patients treated for symptomatic benign prostatic hyperplasia.
More Articles by Jody A. Charnow, Editor
- Genomic Prostate Score Predicts PCa Recurrence, Adverse Pathology
- New Dyslipidemia Guidelines Eliminate Treatment Targets
- Complications More Likely After Radiotherapy vs. Surgery for PCa
- High-Risk Patients Screened for Bladder Cancer Rarely Die from It
- Weekend Hospitalizations Worsen Outcomes for Metastatic PCa Patients
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)